Compare VanEck Junior Gold Miners (GDXJ) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Junior Gold Miners vs Immunovant Inc. Common Stock — how do they compare? VanEck Junior Gold Miners trades at $114.2 (market cap $8.22B), while Immunovant Inc. Common Stock trades at $30.49 (market cap $6.25B). The key difference: VanEck Junior Gold Miners is the larger of the two by market cap, and VanEck Junior Gold Miners is more actively traded (3,212,198 versus 1,755,411). Which is the better fit depends on your goals — on Pluang, investors hold VanEck Junior Gold Miners for 41 Days and Immunovant Inc. Common Stock for 0 Days on average.
| GDXJ | IMVT | |
|---|---|---|
Market Cap | $8.22B | $6.25B |
Volume | 3,212,198 | 1,755,411 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $156.19 | $44.96 |
52-Week Low | $87.56 | $17.03 |
Typical Hold Time | 41 Days | 0 Days |
Enterprise Value | — | $5.35B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GDXJ, the VanEck Junior Gold Miners ETF, trades at $113.02, up 3.56% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF is undergoing significant rebalancing, with multiple junior mining companies added in September 2026, potentially increasing diversification. Key support lies at $110, with resistance at $113. Financial ratios are not applicable as this is a fund tracking an index of gold mining equities.
The outlook remains cautious due to bearish technicals, though inclusion of new holdings may attract flows. Risks include gold price volatility and mining sector operational challenges. Analyst views on constituent stocks vary, but the ETF offers exposure to small-cap gold miners, which can be high-risk, high-reward during gold rallies.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VanEck Junior Gold Miners
GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
